Evidence map›Paper›PMID 30543657›Full record

Trial reportPloS one2018

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.

Chloé Pasin, M Elizabeth Halloran, Peter B Gilbert, Edith Langevin, R Leon Ochiai, Punnee Pitisuttithum, Maria Rosario Capeding, Gabriel Carrasquilla, Carina Frago, Margarita Cortés and 2 more

Abstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chloé PasinUniversité de Bordeaux, INSERM U1219 Bordeaux Population Health center, INRIA SISTM, Bordeaux, France.ORCID 0000-0001-8730-790X
M Elizabeth HalloranFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Peter B GilbertFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Edith LangevinSanofi Pasteur, Marcy L'Etoile, France.
R Leon OchiaiSanofi Pasteur, Singapore, Singapore.
Punnee PitisuttithumVaccine Trial Centre and Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Nakorn Pratum, Thailand.
Maria Rosario CapedingResearch Institute for Tropical Medicine, Alabang, Muntinlupa City, Philippines.
Gabriel CarrasquillaFundación Santa Fe de Bogotá, Bogotá, Colombia.
Carina FragoSanofi Pasteur, Singapore, Singapore.
Margarita CortésSanofi Pasteur, Bogotá, Colombia.
Laurent ChambonneauSanofi Pasteur, Marcy L'Etoile, France.
Zoe MoodieFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Funding

Methods for Evaluating Vaccine EfficacyR37AI032042 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HALLORAN, M ELIZABETH · 2010 to 2019
$5.1M
NIAID NIH HHS R37 AI032042
6 · The paper itself

Abstract

objectiveTo evaluate the association of rainy season with overall dengue disease incidence and with the efficacy of the Sanofi Pasteur recombinant, live, attenuated, tetravalent vaccine (CYD-TDV) in two randomized, controlled multicenter phase III clinical trials in Asia and Latin America.

methodsRainy seasons were defined for each study site using climatological information from the World Meteorological Organization. The dengue attack rate in the placebo group for each study month was calculated as the number of symptomatic, virologically-confirmed dengue events in a given month divided by the number of participants at risk in the same month. Time-dependent Cox proportional hazard models were used to test whether rainy season was associated with dengue disease and whether it modified vaccine efficacy in each of the two trials and in both of the trials combined.

findingsRainy season, country, and age were all significantly associated with dengue disease in both studies. Vaccine efficacy did not change during the rainy season in any of the analyses.

conclusionsAlthough dengue transmission and exposure are expected to increase during the rainy season, our results indicate that CYD-TDV vaccine efficacy remains constant throughout the year in endemic regions.

Indexed as

AdolescentAsiaChildDengueDengue VaccinesEndemic DiseasesFemaleHumansLatin AmericaMaleRainSeasonsTreatment OutcomeVaccines, AttenuatedCYD-TDV vaccineDengue VaccinesVaccines, Attenuated

Identifiers

PMID30543657
PMCPMC6292612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.